Spero Therapeutics Inc.

NASDAQ: SPRO · Real-Time Price · USD
1.93
-0.05 (-2.53%)
At close: Aug 15, 2025, 3:59 PM
2.00
3.88%
After-hours: Aug 15, 2025, 07:31 PM EDT

Spero Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Cash & Equivalents
31.19M 48.89M 52.89M 76.29M 63.53M 82.27M 76.33M 93.83M 77.69M 96.25M 109.11M 50.45M 45.4M 72.11M 112.58M 112.86M 71.56M 77.04M
Short-Term Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 49.85M 33.82M 10.56M 27.66M 38.63M
Long-Term Investments
n/a n/a n/a n/a 23.59M 23.21M 46.59M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Long-Term Assets
153K 153K 153K 153K 434K 434K 435K 434K 5.74M 5.74M 10.2M 5.74M 5.47M 5.93M 5.64M 5.21M 5.21M 5.52M
Receivables
26.91M 24.28M 52.48M 53.28M 55.49M 54.22M 50.7M 2.99M 2.09M 1.86M 1.08M 953K 1.58M 1.99M 2.64M 2.58M 2.2M 8.62M
Inventory
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a -4.46M n/a n/a n/a n/a n/a n/a n/a
Other Current Assets
1.29M 1.55M 1.91M 2.06M 3.2M 3.67M 4.18M 5.41M 8.57M 3.54M 3.38M 1.49M 4.97M 8.75M n/a 5.77M 4.9M n/a
Total Current Assets
59.4M 74.71M 107.28M 131.63M 122.22M 140.15M 131.21M 102.22M 88.35M 101.66M 109.11M 52.89M 51.95M 132.7M 157.87M 131.77M 106.32M 129.49M
Property-Plant & Equipment
2.56M 2.84M 3.11M 3.38M 3.64M 3.9M 4.16M 4.45M 4.8M 5.14M 5.49M 5.85M 6.21M 7.2M 7.56M 7.71M 8.07M 8.43M
Goodwill & Intangibles
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Total Long-Term Assets
2.72M 3M 3.27M 3.53M 27.66M 27.55M 51.18M 4.88M 10.54M 10.88M 15.7M 11.59M 11.67M 13.13M 13.2M 12.92M 13.28M 13.95M
Total Assets
62.12M 77.71M 110.54M 135.16M 149.88M 167.7M 182.39M 107.1M 98.89M 112.55M 124.8M 64.48M 63.63M 145.83M 171.07M 144.69M 119.59M 143.44M
Account Payables
780K 1.76M 7.31M 6.09M 2.7M 3.07M 1.38M 1.1M 1.31M 583K 617K 2.58M 1.71M 4.78M 1.1M 3.16M 1.63M 3.83M
Deferred Revenue
5.43M 17.23M 22.12M 25.84M 30.81M 31.26M 27.11M 13.87M 8.71M 11.85M 10.37M 3.73M 2.36M 2.09M 1.86M 1.7M 1.18M -980K
Short-Term Debt
1.84M n/a n/a n/a n/a 1.73M 1.72M 1.71M 1.7M 1.7M n/a 1.68M 1.53M 50.9M n/a 1.04M 1.01M 980K
Other Current Liabilities
2.54M n/a n/a 12.05M n/a -1.73M -1.72M -1.71M 4.47M 3.81M n/a 1.69M 4.89M 58.56M n/a 6.29M 5.5M 10.66M
Total Current Liabilities
14.95M 29.16M 49.07M 49.1M 45.63M 41.82M 37.15M 25.46M 17.32M 22.99M 21.65M 16.23M 14.23M 69.2M 18.67M 17.26M 12.83M 17.76M
Long-Term Debt
1.77M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Long-Term Liabilities
n/a 12.57M 576K 13K 25K 38K 87K 62K 72K 85K 96K 107K 117K 128K 49.35M 148K 158K 168K
Total Long-Term Liabilities
14.35M 14.74M 15.35M 20.56M 23.75M 29.63M 38.34M 27.93M 26.78M 24.72M 27.22M 15.77M 13.48M 14.16M 64.11M 15.54M 16.52M 6.83M
Total Liabilities
29.29M 43.9M 64.42M 69.65M 69.38M 71.45M 75.5M 53.4M 44.1M 47.71M 48.87M 31.99M 27.7M 83.36M 82.78M 32.8M 29.34M 24.59M
Total Debt
3.62M 3.96M 4.3M 4.62M 4.94M 5.24M 5.54M 5.83M 6.11M 6.38M 6.65M 6.9M 7M 7.09M 7.33M 7.23M 7.44M 7.64M
Common Stock
56K 56K 55K 54K 54K 54K 53K 53K 53K 53K 52K 43K 35K 33K 32K 32K 30K 30K
Retained Earnings
-475.2M -473.5M -459.64M -438.75M -421.6M -403.74M -391.07M -442.26M -439.06M -427.14M -413.88M -440.65M -428.97M -400.29M -367.46M -338.22M -315.7M -297.13M
Comprehensive Income
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a -6K -2K -2K -2K -3K
Shareholders Equity
32.83M 33.81M 46.12M 65.51M 80.5M 96.25M 106.89M 53.7M 54.78M 64.84M 75.93M 32.48M 35.92M 62.47M 88.29M 111.89M 90.25M 118.85M
Total Investments
n/a n/a n/a n/a 23.59M 23.21M 46.59M n/a n/a n/a n/a n/a n/a 49.85M 33.82M 10.56M 27.66M 38.63M